Select Language

  • Home
  • The Compendium
  • Featured Issues
  • Media Library
  • Vaccine Resources
  • Advocacy
  • About
Navigation Menu
  • Home
  • The Compendium
  • Featured Issues
  • Media Library
  • Vaccine Resources
  • Advocacy
  • About

Disease or Vaccine: Pertussis

The impact of the U.S. maternal Tdap vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation

May 21, 2019

By Kirthini Muralidharan

Maternal vaccination in Argentina: tetanus, diphtheria, and acellular pertussis vaccine effectiveness during pregnancy in preventing pertussis in infants <2 months of age

May 21, 2019

By Kirthini Muralidharan

Cost-effectiveness analysis of universal maternal immunization with Tdap vaccine in Brazil

May 17, 2019

By Kirthini Muralidharan

Cost-effectiveness of analysis of pertussis vaccination during pregnancy in Japan

May 17, 2019

By Kirthini Muralidharan

Cost-effectiveness of pertussis vaccination during pregnancy in the US

May 17, 2019

By Kirthini Muralidharan

Coverage, Timelines, and Determinants of Incomplete Immunization in Bangladesh

May 9, 2019

By Kirthini Muralidharan

Nosocomial pertussis: Costs of an outbreak and benefits of vaccinating health care workers

May 6, 2019

By Kirthini Muralidharan

Determinants of delayed or incomplete diphtheria-tetanus-pertussis vaccination in parallel urban and rural birth cohorts of 30,956 infants in Tanzania.

May 6, 2019

By Kirthini Muralidharan

Timeliness and completeness of vaccination and risk factors for low and late vaccine uptake in young children living in rural southern Tanzania.

July 1, 2018

By Brooke Farrenkopf

Modelling the return on investment of preventatively vaccinating healthcare workers against pertussis

April 19, 2018

By Earthling Interactive

Posts navigation

Older posts
Newer posts

Web Policies      Translation Disclaimer

VoICE is a project of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Johns Hopkins Bloomberg School of Public Health
www.jhsph.edu/ivac

Please email the VoICE editor with any questions or comments.

  • Contact Us
  • twitter

Stay Connected

© 2023, The International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. All rights reserved.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Learn more from the Johns Hopkins University Privacy Statement.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT